No deal might be the best outcome for dividend-seeking investors. It’s a story as old as time. Two Dividend Aristocrats meet, ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

Her fake crocodile purse always contained the following: Dristan nasal spray, a $1 bill, a comb, Kleenex, a roll of Certs, a ...

In one of the most significant consumer-goods mergers of the year, Kimberly-Clark is buying Tylenol maker Kenvue in a ...

Kleenex maker Kimberly-Clark will buy Kenvue at a 46% premium, tanking its own stock by 13%. Synergies promise a decent return to numb the pain of a high price. It’s an opportunistic bet that claims ...

Aid, Huggies, and Kleenex are now under one roof. In a major business deal worth $48.7 billion, Kimberly-Clark, the company behind Huggies diapers and Kleenex tissues, is buying Kenvue, […] The post ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

NEW YORK (Reuters) -Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's ...

Kimberly-Clark to acquire Kenvue in a 48.7 billion deal, creating a consumer health giant with 32 billion in annual sales, facing market skepticism over pricing, leverage, and promised savings.

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue ...